Virendra Tiwari

Assistant Professor

Department of Pharmacology

GITAM School of Pharmacy

Hyderabad

Education

Ph. D.

vtiwari@gitam.edu

Social Media

Google Scholar Scopus

Scopus

ORCiD

Dr. Virendra Tiwari is presently employed as an assistant professor at the GITAM School of Pharmacy, Hyderabad. He obtained his PhD from the CSIR-CDRI in Lucknow. Research Experience: Postdoctoral Research Fellow at Tulane University, LA, and the University of Missouri–Kansas City, MO, USA. His research interests include neurobiology, ischemic stroke, cognition, neuroplasticity, and neurogenesis. He has authored 20 research publications, 2 review articles, and 3 book chapters.

Research Publications

1. Sun W, Tiwari V, Davis G, Zhou G, Jonchhe S, Zha X. Time-Dependent Potentiation of the PERK Branch of UPR by GPR68 Offers Protection in Brain Ischemia. Stroke. 2024 Sep 3. doi: 10.1161/STROKEAHA.124.048163. Epub ahead of print. PMID: 39224971
2. Kour A, Tiwari V, Aggarwal N, Sekhar Panda H, Kumar A, Tiwari S, Chauhan VS, Shukla S, Panda JJ. Anti-amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimers disease. Nanoscale. 2023 Aug 315(30):12748-12770. doi: 10.1039/d3nr01558k. PubMed PMID: 37477348.
3. Tiwari V, Mishra A, Singh S, Shukla S. Caffeine improves memory and cognition via modulating neural progenitor cell survival and decreasing oxidative stress in Alzheimers rat model. Curr Alzheimer Res. 2023 Jun 5. doi: 10.2174/1567205020666230605113856. Epub ahead of print. PMID: 37282567.
4. Tiwari V, Singh J, Tiwari P, Chaturvedi S, Gupta S, Mishra A, Singh S, Wahajuddin M, Hanif K, Shukla S. ACE2/ANG-(1-7)/Mas receptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimers disease-like phenotypes. Eur J Pharmacol. 2023 Mar 3:175623. doi: 10.1016/j.ejphar.2023.175623. Epub ahead of print. PMID: 36871666
5. Tiwari P, Tiwari V, Gupta S, Shukla S, Hanif K. Activation of Angiotensin-converting Enzyme 2 Protects Against Lipopolysaccharide-induced Glial Activation by Modulating Angiotensin-converting Enzyme 2/Angiotensin (1-7)/Mas Receptor Axis. Mol Neurobiol. 2022 Oct 17. doi: 10.1007/s12035-022-03061-5. Epub ahead of print. PMID: 36251234

Expertise

Middle Cerebral Artery Occlusion (MCAO), Stereotaxic Surgery, Behavioural parameters, Immunoblotting, rt-PCR

Authored Books

1. Tiwari V*, Mishra A*, Singh S, Parul, Tripathi P, Shukla S. Emerging Novel Approaches and Recent Advances in Parkinsons Disease Treatment and Diagnosis, Frontiers in Clinical Drug Research CNS and Neurological Disorders (2022) 10: 60. https://doi.org/10.2174/9789815040678122100004
2. Mishra A*, Tiwari V*, Singh S, Shukla S. Chapter 21 Experimental Models to Study Alzheimers Disease. Alzheimers Disease: Recent Findings in Pathophysiology, Diagnostic and Therapeutic Modalities: The Royal Society of Chemistry 2022. p. 591-607 https://doi.org/10.1039/9781839162732-00591.
3. Tiwari V, Mishra A, Singh S, Shukla S. Chapter 6. P-Glycoprotein: A New Insight in the Field of Neurogenesis with a Different Perspective. An Introduction to P-Glycoprotein: Nova Science Publishers, Inc. 2021.(2)